TRAXV First Tracks Biotherapeutics, Inc.

Fundamentals / CIK 0002091349 / USD
Other share classes on CIK 0002091349: TRAX

First Tracks Biotherapeutics, Inc. reported $170.5M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRAXV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for TRAXV.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $23.85M $25.64M $33.95M $33.32M $39.27M $41.47M
Total Operating Expenses $32.84M $34.94M $52.81M $45.06M $45.90M $51.28M
Operating Income -$32.84M -$34.94M -$52.81M -$45.06M -$45.90M -$51.28M
EBITDA -$32.75M -$34.83M -$52.69M -$44.92M -$45.76M -$51.13M
Interest Income $1.50M $1.56M $2.33M $3.20M $3.47M $4.09M
Net Income -$31.36M -$33.37M -$50.48M -$41.86M -$42.45M -$47.20M
Basic EPS -$0.88 -$0.95 -- -$1.50 -$1.47 --
Diluted EPS -$0.88 -$0.95 -- -$1.50 -$1.47 --
Basic Shares Outstanding 35.7M 35.0M -- 27.8M 28.8M --
Diluted Shares Outstanding 35.7M 35.0M -- 27.8M 28.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for TRAXV.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $155.6M $168.0M $248.5M $238.2M
Short-Term Investments $0 $0 $37.99M $73.44M
Cash & Short-Term Investments $155.6M $168.0M $286.5M $311.6M
Other Current Assets $2.01M $2.18M -- $1.88M
Total Current Assets $165.7M $177.7M $289.4M $316.4M
Property, Plant & Equipment, Net $979K $1.07M $1.17M $1.37M
Other Non-Current Assets $0 $0 $0 $256K
Total Non-Current Assets $4.73M $5.39M $1.17M $14.14M
Total Assets $170.5M $183.1M $290.6M $330.5M
Accounts Payable $3.95M $2.55M $7.50M $3.11M
Total Current Liabilities $18.09M $12.45M $33.11M $31.02M
Total Non-Current Liabilities $1.35M $1.90M $0 $12.03M
Total Liabilities $19.45M $14.34M $33.11M $43.05M
Total Debt (incl. Leases) $3.77M $4.33M -- $14.11M
Common Stock $36K $35K -- $0
Retained Earnings -$55.93M -$24.58M -- $0
Accumulated Other Comp. Income $0 $0 -$146K -$24K
Total Stockholders' Equity $151.0M $168.8M $257.5M $287.5M
Total Equity $151.0M $168.8M $257.5M $287.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for TRAXV.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$31.36M -$33.37M -$50.48M -$41.86M -$42.45M -$47.20M
Depreciation & Amortization $92K $105K $125K $140K $142K $146K
Stock-Based Compensation $8.90M $8.32M $11.50M $9.85M $7.66M $7.75M
Operating Cash Flow -$17.05M -$31.92M -$32.56M -$30.69M -$38.64M -$45.01M
Capital Expenditure $0 -$25K -$17K -$12K -$39K -$35K
Free Cash Flow -$17.05M -$31.94M -$32.58M -$30.70M -$38.68M -$45.04M
Purchases of Investments $0 $0 $0 -$19.66M -$54.21M -$122.5M
Investing Cash Flow $0 -$25K $34.98M $103.3M $36.40M $14.85M
Financing Cash Flow $4.66M -$48.51M $7.85M -$7.06M -$52.10M $5.72M
Net Change in Cash -$12.39M -$80.45M $10.27M $65.53M -$54.34M -$24.44M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for TRAXV.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 9.16x 14.28x 8.74x -- -- --
Quick Ratio 8.60x 13.50x 8.65x -- -- --
Debt to Equity 0.02x 0.03x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002091349) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal